Jerome Wang, MD
Pediatrics · Yorba Linda, CANPI 1326076746
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.7% of the total across 18 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 17.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $225, 5.7 times the $40 reported in 2019.
Across 18 payments — averaging $25.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$79
- Sanofi-aventis U.S. LLC$73
- GSK$51
- Boehringer Ingelheim$42
- Sanofi Pasteur Inc.$39
- Lilly USA, LLC$38
- plus $136 from 5 others
What the payments were for
- Consulting fees$204%
- Food & beverage$43896%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 3 | $79 |
| Sanofi-aventis U.S. LLC | 2 | $73 |
| GSK | 2 | $51 |
| Boehringer Ingelheim | 2 | $42 |
| Sanofi Pasteur Inc. | 2 | $39 |
| Lilly USA, LLC | 2 | $38 |
| Merck | 1 | $34 |
| Mayne Pharma Commercial LLC | 1 | $33 |
| Verrica Pharmaceuticals Inc. | 1 | $25 |
| Johnson & Johnson | 1 | $24 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $20 |
How this compares
$458 in reported general payments places this provider in the 70th percentile of 5,539 pediatrics providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Losartan Potassium | 38 | $488 |
| Levothyroxine Sodium | 29 | $351 |
| Atorvastatin Calcium | 43 | $349 |
| Tamsulosin Hcl | 19 | $323 |
| Rosuvastatin Calcium | 13 | $319 |
| Fluticasone Propionate | 15 | $280 |
| Omeprazole | 13 | $178 |
| Simvastatin | 25 | $156 |
| Metformin Hcl | 23 | $111 |
| Lisinopril | 20 | $91 |
| Alendronate Sodium | 11 | $74 |
| Amlodipine Besylate | 16 | $69 |
| Sertraline Hcl | 19 | $61 |
| Zolpidem Tartrate | 13 | $23 |
Paid to pharmacies, not to this prescriber.
Other pediatrics in Yorba Linda
- Laurene MascolaLos Angeles$451K
- Tonya ChaffeeSan Francisco$359K
- Anthony PortaleSan Francisco$354K
- David KesslerSan Francisco$335K
- Lawrence SherRolling Hills Estates$297K
- Steven BlackOakland$228K
- Jonathan StroberSan Francisco$164K
- Hasmukh AminBakersfield$140K
- Colleen KraftNewport Beach$122K
- Lela BachrachOakland$119K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.